A bedside guide to defining the problem space before choosing how to reason or act
How to use this guide
This is a rapid orientation tool for consultants, trainees, and clinicians.
Its purpose is to help you answer one question at the moment of the consult:
What kind of problem space am I in right now?
Within Consult Practice:
- Orientation defines the map
- Thinking determines stance within that map
- Execution translates that stance into visible action and communication
This guide constrains what kind of danger is plausible, how urgent the situation may be, and how much uncertainty the moment can tolerate.
It does not teach reasoning.
It does not instruct action.
If you finish this guide knowing what to do, it has gone too far.
What “problem space” means
A problem space describes:
- what kinds of danger are plausible,
- what types of explanations are relevant,
- how fast the situation may evolve,
- and how much uncertainty can safely be tolerated.
Two patients with identical hemoglobin values may occupy entirely different problem spaces depending on stability, trajectory, and thrombotic context.
Orientation explains why.
Relationship to reference resources
Guidelines, order-sets, and point-of-care resources assume that the problem space has already been defined.
This guide helps you decide:
- which reference frame applies,
- and whether the situation is immediate danger, evolving risk, or contained physiology.
Orientation is complementary, not competitive.
Universal first check
Before framing the problem:
- confirm the hemoglobin trajectory, not just the value
- confirm whether the bleeding is active, recent, or historical
- identify the anticoagulant and timing of last dose
- assess hemodynamic stability
- determine whether other teams (GI, ICU) are already engaged
- do not assume that anticoagulation is the cause simply because it is present
This step defines what kind of terrain you are in, not what the diagnosis is.
Core orientation lenses
These are orients, not steps.
They do not have to be addressed in order.
Each one narrows what kind of danger this might represent.
Orient 1 — How dangerous could this be right now?
This is the first and most important question.
Active bleeding in an anticoagulated patient can represent:
- immediate hemorrhagic instability,
- a stable but evolving blood-loss pattern,
- or a contained physiologic event.
This orient constrains urgency, not management.
Orient 2 — How recent and how severe is the thrombotic history?
Anticoagulation carries meaning only relative to the recency and severity of thrombosis. This orient constrains risk balance, not diagnosis.
A patient anticoagulated for a pulmonary embolism last week occupies a different terrain than one anticoagulated for a remote DVT years ago.
This orient constrains risk balance, not diagnosis.
Orient 3 — Is the bleeding disproportionate to the clinical context?
Define whether the bleeding suggests:
- catastrophic instability,
- expected anticoagulation-related vulnerability,
- or coincidental overlap.
Do not unify prematurely.
Orient 4 — Is this an isolated bleeding issue, or part of a broader hematologic pattern?
Look for:
- thrombocytopenia,
- coagulopathy,
- or multi-lineage decline.
Bleeding alone is one terrain.
Bleeding as part of systemic hematologic derangement is another.
Orient 5 — What does the trajectory suggest about tempo?
A rapidly falling hemoglobin defines a very different terrain than a stable or fluctuating one.
Orientation focuses on how fast things may be changing, not why.
Concrete comparison
| Patient | Hemoglobin | Context | Trajectory | Problem Space |
|---|---|---|---|---|
| A | 8.2 | Anticoagulated for remote DVT | Stable | low-urgency overlap |
| B | 8.2 | Anticoagulated for recent PE | Falling quickly with active GI bleed | competing-harms terrain requiring vigilance |
Same numbers.
Different terrain.
Orientation explains the difference.
Common traps to avoid
- treating bleeding as automatically anticoagulant-driven
- assuming thrombosis and bleeding must be unified
- escalating before stability and tempo are clear
- reassuring too early based on appearance alone
- ignoring trajectory and thrombotic recency
- confusing laboratory abnormality with immediate danger
Orientation protects against these errors.
Functional problem spaces this guide identifies
This orientation helps define whether you are in:
- Immediate hemorrhagic danger terrain
- Competing-harms terrain (bleeding and thrombosis both relevant)
- Contained or stable physiology terrain
- Broader hematologic-system terrain
- Evolving picture requiring close surveillance
Each of these terrains demands a different kind of Thinking and Execution.
Bottom line
Anticoagulation with bleeding is not a diagnosis.
Orientation answers:
- how dangerous this situation could be,
- how broad the terrain is,
- how much uncertainty the moment tolerates,
- and what kind of thinking and execution posture should follow.
Define the map first.
Then engage:
➡️ Thinking to decide how to reason
➡️ Execution to make judgment visible through action and communication
Terms used in this guide
Problem space
The clinical world the patient currently inhabits: what kinds of danger are plausible, how fast the situation may evolve, and how much uncertainty can be tolerated safely before meaning is clarified.
Terrain
A functional description of the situation that constrains what kinds of dangers and explanations belong in the frame (for example, isolated bleeding vs systemic hematologic derangement), without naming a diagnosis.
Tempo
The speed at which the situation is changing. In bleeding, tempo is often defined by trajectory (hemoglobin change, ongoing blood loss) and physiologic stability rather than by the numeric hemoglobin value alone.
Trajectory
The direction and rate of change over time (falling, stable, fluctuating). Trajectory often determines urgency more than a single measurement.
Physiologic stability
Whether the patient’s circulation and perfusion appear steady or threatened (for example, hemodynamics, symptoms of hypoperfusion). In Orientation, stability is used to define danger plausibility, not to direct actions.
Immediate hemorrhagic danger terrain
A problem space in which harm could occur quickly if bleeding is underestimated because physiology is unstable, blood loss is ongoing, or reserve appears brittle.
Evolving blood-loss terrain
A problem space in which the patient is not yet unstable but trajectory suggests that deterioration is plausible (for example, falling hemoglobin or ongoing bleeding), requiring close surveillance of tempo.
Contained or stable physiology terrain
A problem space in which bleeding appears limited or resolved and physiology is stable, allowing greater uncertainty tolerance while the meaning is clarified.
Competing-harms terrain
A problem space in which both bleeding risk and thrombotic risk plausibly matter at the same time, because anticoagulation cannot be interpreted without the recency and severity of thrombosis.
Thrombotic recency
How recently a clinically meaningful thrombotic event occurred. Recent events constrain the problem space more tightly than remote events because the cost of interruption may be higher.
Thrombotic severity
The clinical consequence and baseline risk of the thrombotic condition (for example, high-risk VTE vs lower-risk indication). Severity helps define how “expensive” uncertainty is when bleeding is present.
Disproportionate bleeding
Bleeding whose severity or tempo appears out of scale with the apparent clinical context. In Orientation, “disproportionate” is a terrain signal that widens what must remain plausible.
Broader hematologic-system terrain
A problem space in which bleeding is not isolated but occurs alongside thrombocytopenia, coagulopathy, multi-lineage cytopenias, or systemic illness, expanding plausible danger beyond anticoagulant effect alone.
Uncertainty tolerance
How much “not knowing” can be safely carried in the next hours, given tempo, stability, and the costs of being wrong in either direction.